anti-PD1 treatmentimmune checkpoint therapyTNG260pembrolizumab
…t CoREST inhibition by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,341–2,400 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Interferential therapy (IFT)1Intestinal transplant1Intestinal ultrasound1Intra-articular corticosteroid (IACS) injection1Intra-articular corticosteroid injections1Intracerebral dopamine cell transplants1Intralesional corticosteroid therapy1Intrapleural fibrinolytic treatment1Intrasaccular flow disruption1Intrathecal drug delivery1Intratympanic steroid therapy1Intravenous (IV) fluid therapy1Intravenous medicine administration1Intravenous potassium supplementation1Intravesical BCG instillations1Intravitreal antivascular endothelial growth factor (anti-VEGF) therapy1Intravitreal therapies1Irreversible electroporation (IRE)1JAK inhibitors1Joint replacement1Jugular vein stenting1K-wire fixation1Ketamine-assisted psychotherapy1LAMS1LD-XRT1LDKTrelativeyearsgained1LDKTsurvival1LN induction treatment1LPA-targeted therapies1LRT1LTNIV1LV lead placement1LVAD implantation1LVR1Labor analgesia1Labour epidural analgesia1Laparoscopic surgery1Laparoscopy1Lateral femoral cutaneous nerve block1Left atrial ablation1Left ventricular assist devices1Level 1 disability management1Lipid Lowering TherapyPrescribed1Lipid-lowering therapies1Lokomat rehabilitation1Long term dopamine agonist therapy1Long-acting antiretroviral therapy1Long-acting injectable antiretroviral therapy1Low-dose ketamine infusion1Lumbar spine surgeries1Lymphatic Microsurgical Preventive Healing Approach1Lymphaticovenous anastomosis (LVA)1MATRix protocol1MB-TRAIL M28z CAR-T cell therapy1MBC regimen1MBE1MCMV peptide-epitope therapy1MDMA-assisted psychotherapy1MDT1MDT therapy programmes1
Articles mentioning treatments
7,227 articles · page 231 of 603lymphodepleting chemotherapyAGX-148oral head and neck squamous cell carcinomamelanomathyroid cancersolid tumorsProvidence Institutional Review BoardClinicalTrials.gov
…ard and experimental therapies. Patients undergo tumor harvest, lymphodepleting chemotherapy, adoptive transfer of AGX-148 and high-dose IL-2 for one week, …
immunotherapyNanO 2Glioblastoma MultiformeNanO2PaclitaxelTNBCTriple-negative breast cancerDOD GrantBALB/c mice
… experiments, we tested the effect of NanO2 in combination with immunotherapy (IT), chemotherapy (CTX, paclitaxel) or both IT and CTX. BALB/c…
Triplet therapyanthracycline chemotherapyFTY720Flt3LTNBCDoxil D1NCT05029999
…s) as well as by blocking lymphocyte egress with FTY720.Results Triplet therapy significantly delayed tumor progression and extended median sur…
immunotherapyBreast cancerQUICKARRAYS, Inc
…y mapped the TME to identify features potentially predictive of immunotherapy response. FFPE (Formalin-Fixed Paraffin-Embedded) tissue slide …
T-FUSUniversity of Virginiacancerbreast cancerBCNIH DP5OD031846αCD40
…t of CD4+ T cells following rechallenge (figure 2O).Conclusions T-FUS+αCD40 represents a novel paradigm for immunotherapy of BC-capab…
anti-PD-1 therapyPD-1 therapyMD Anderson Cancer CenterKAN-001non-small cell lung cancerNSCLCCRCHUMCanadian Council
… evaluated in the MCA205 murine tumor model in combination with anti-PD-1 therapy. Comparative arms included treatment with FMT from ICI-non-resp…
immune checkpoint blockadeHER2-targeted therapyLeica BiosystemsIndica Labsgastric and gastroesophageal junction (GEJ) adenocarcinomaHER2-amplified colorectal cancerHER2-low breast cancerHER2-positive breast cancer
…, suggesting possible synergy between HER2-targeted therapy and immune checkpoint blockade.In HER2-amplified colorectal cancer, PD-L1 expression and immun…
immunotherapychemotherapyMassachusetts General HospitalMGH Histopathology Research CoreTNBCImmunomedics/GileadSacituzumab govitecantriple-negative breast cancerhuman breast cancer
…ody drug conjugates to activate anti-tumor immunity and enhance immunotherapy response.Acknowledgements We gratefully acknowledge Immunomedic…
Adoptive CTL therapyimmunotherapymelanoma-specificExtramammary Paget’s disease (EMPD)IL-2EMPDmelanomaRadiother Oncolsolid tumorsEBV-related cancers+1 more
…es in solid tumors, yet limited data exist in the EMPD context. Adoptive CTL therapy, which involves the ex vivo expansion and activation of autolog…
ImmunotherapyAzaAzacytidineAMLAcute Myeloid Leukemia
… AML has remained largely unchanged over the last four decades. Immunotherapy is a promising therapy in many cancers including AML. T cell ex…
immunotherapyEwing SarcomaChildren’s Oncology GroupIL1RAP
…on of the immune environment in ES may reveal the blockades for immunotherapy efforts and potential new pathways to be exploited in the futur…